跳至主要内容
临床试验/NCT03462303
NCT03462303已完成不适用

Modulation of Cognitive Flexibility by Tyrosine Depletion and Transcranial Direct Current Stimulation

Sheffield Hallam University2 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2018年2月12日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
36
试验地点
2
主要终点
Change in cognitive flexibility performance

研究概览

简要总结

The dorsolateral prefrontal cortex (dlPFC) and dopamine (DA) have been implicated in the control of cognitive flexibility. However, while a great deal of what it is know regarding a causative relationship between cognitive flexibility and its neuronal underpinning comes from animal studies, human data have largely been correlational (i.e. imaging investigations). In a recent study, the current research group examined whether putative increases in dopamine levels through tyrosine administration and blockage of these by cathodal (i.e. inhibitory) transcranial direct current stimulation (tDCS) of the dlPFC could be causally related to cognitive flexibility as measured by task switching and reversal learning.

The next step involves finding a way of lowering dopamine concentrations while anodal (i.e. excitatory) stimulation of the dlPFC is applied and cognitive flexibility measured. One experimental approach to reduce global DA synthesis and transmission is through acute phenylalanine and tyrosine depletion (APTD). This dietary intervention involves the administration of an amino-acid mixture lacking in tyrosine and phenylalanine, which can be used to selectively lower DA synthesis in humans.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Either male or female
  • You are aged between 18 and 30 years
  • You are in good health
  • You agree to fast overnight prior to testing

排除标准

  • Are suffering from cardiac, hepatic, renal, or neurological disorders
  • Damaged or diseased skin on your face and scalp, or a sensitive scalp
  • A history of alcohol or drug addiction, or severe psychiatric illness
  • Are in drug treatment which may lower seizure threshold (i.e. epilepsy)
  • You are pregnant
  • Slept less than 6 hours prior to coming to the lab
  • Suffer from phenylketonuria
  • A history of or current experience of migraine or headaches
  • A history of or current use of antidepressants
  • A history of or current use of tyrosine supplements
  • Consume more than five beverages containing caffeine per day

研究组 & 干预措施

tDCS sham + balanced drink

Placebo Comparator

干预措施: Sham tDCS and balanced drink (Combination Product)

tDCS sham + tyrosine depleted drink

Experimental

干预措施: Sham tDCS and tyrosine depleted drink (Combination Product)

tDCS anodal + balanced drink

Experimental

干预措施: Anodal tDCS and balanced drink (Combination Product)

tDCS anodal +tyrosine depleted drink

Experimental

干预措施: Anodal tDCS and tyrosine depleted drink (Combination Product)

结局指标

主要结局

Change in cognitive flexibility performance

时间窗: Measured over 5 hours. 1st measurement taken at baseline (i.e. time 0). 2nd measurement taken 120 minutes after measurement 1. 3rd measurement taken 220 minutes after measurement 1. 4th measurement taken 270 minutes after measurement 1.

Measured using Probabilistic Reversal Learning

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验